Combined MTX-5FU-CBDCA for the Treatment of Head and Neck Cancer.

Practica Otologica- Japan

doi 10.5631/jibirin.95.81

Full Text

Abstract

Available in

Date

Authors

Publisher

The Society of Practical Otolaryngology

Related search

Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
1995English

Prereferral Head and Neck Cancer Treatment

Archives of Otolaryngology–Head & Neck Surgery
2010English

Treatment De-Intensification Strategies for Head and Neck Cancer

European Journal of Cancer
Cancer ResearchOncology
2016English

Hypothyroidism After Treatment for Nonthyroid Head and Neck Cancer

Archives of Otolaryngology–Head & Neck Surgery
2000English

Ethical Considerations in the Treatment of Head and Neck Cancer

Cancer Control
MedicineOncologyHematology
2002English

Immunotherapy for Head and Neck Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2011English

Head and Neck Cancer

Journal of Oncology
Oncology
2009English

The Lived Experience of Dysphagia Following Non-Surgical Treatment for Head and Neck Cancer

International Journal of Speech-Language Pathology
LinguisticsTheoryLanguageResearchOtorhinolaryngologyLPNSpeechLVNHearing
2013English

The Symptom Burden of Treatment-Naive Patients With Head and Neck Cancer

Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy